|
Technology |
| Our technology focuses on using Ramanprobes technology to enhance existing biospecific labeling applications and enable future applications. |
|
 |
|
 |
Technology |
 |
Extrinsic Raman label (ERL) reagents combined with
the Nanoraman instrument provide a
complete Ramanprobes system capable of
detecting specific components of complex biomolecular assemblies
with exquisite sensitivity and selectivity. Ramanprobes
systems offer significant advantages over current state-of-the-art
fluorescent systems in sensitivity, analytical concurrency,
instrumentation simplification, and development flexibility.
ERL labeled
antibodies are important for both research and diagnostic
applications because they are amenable to sensitive detection
techniques. Though the current ERL reagent
line focuses only on antibody labeling, future products will
include the labeling of antigens, nucleic acids, lectins, and
aptamers to name a few. Considered a primary detection reagent,
our technique uses the principle of a tight association labeling
to confer existence of the antigen.
ERL reagents are
based on our novel strategy exploiting the strong surface enhanced
Raman scattering (SERS)-derived signal from organic dyes (i.e.,
reporter molecules) that are immobilized on Au nanoparticles and
subsequently coupled to the appropriate biospecific species. The
identity of each analyte is determined from the characteristic
SERS spectrum of the nanoparticle-bound reporter species linked to
the tracer antibody, with each antigen then quantified by the
spectral intensity of reporter species. The advantages of this
strategy largely reflect two unique features of SERS. First, the
widths of Raman spectral bands for nearly all organic compounds
are typically 10-100 times narrower than those of fluorescence, a
characteristic that minimizes the potential for spectral overlap
in the response from the different labels. Second, the
intensities of the SERS response for immobilized reporters can
surpass those of fluorescence dyes.

Our Advantages Over Existing Fluorescence Techniques
We are a direct replacement
to fluorescence labeling technology. The following features
of the Ramanprobes system improves current
fluorescence labeling technology by:
 |
The optimum excitation wavelength for SERS depends on
nanoparticle composition and size, but not the immobilized dye
identity, which therefore requires only one excitation source
(e.g., low cost diode laser) for all assays. |
 |
Raman scattering is not affected by fluorescence quenchers
(e.g., oxygen) and is less prone to photobleaching, which not
only facilitates the application of SERS to a wide range of
sample matrices but also enables signal averaging for extended
time periods to lower limits of detection. |
 |
SERS
with Au substrates requires long wavelength excitation (i.e.,
red to near infrared region) for coupling with the surface
plasmon of the substrate, which reduces background from native
fluorescence from the sample. |
 |
Ramanprobes systems have been shown
to be more sensitive. Current levels of detection are down to
1 molecule in 3 seconds. |

Typical Operation
The user combines monoclonal or polyclonal antibodies
for the
target analyte with the ERL 1336 reagent
creating a labeled antibody. The Au Analysis Plate is also
prepared with the target monoclonal or polyclonal antibodies.
The analyte (target) solution is added to the plate. After a
predetermined amount of time, the ERL 1336
reagent prepared in step 1 is then added, and then the plate is
washed. The plate is then placed under the Raman microscope for
analysis. The instrument utilizes a highly monochromatic laser to
illuminate the sample and collect the Raman scattered light.
Because the ERL 1336 label is surface
enhanced, its signal will be approximately 1014 times
stronger than any other Raman signal collected. Because the Raman
spectra of the ERL labels are very narrow,
multiple reagents with different Raman responses (peaks) may be
used with different antibodies (but illuminated concurrently by
the same Raman system).

Publications
Immunoassay Readout Method Using Extrinsic Raman Labels
Adsorbed on Immunogold Colloids, Jing Ni, Robert
J. Lipert, G. Brent Dawson, and Marc D. Porter, Anal. Chem. 1999,
71, 4903-4908.
Nanoparticles with Raman Spectroscopic Fingerprints for DNA and RNA
Detection, Yunwei Charles Cao, Rongchao Jin, Chad A. Mirkin, Science
2002, 297, 1536-1540.
Femtomolar Detection of Prostate Specific Antigen: an Immunoassay Based
on Surface-Enhanced Raman Scattering and Immunogold Labels, Desiree
Grubisha, Robert J. Lipert, Hye-Young Park, Jeremy Driskell, and Marc D.
Porter, Anal. Chem. 2003, 75(21), 5936-5943.
Single Particle Raman Measurements of Gold Nanoparticles Used in
Surface-Enhanced Raman Scattering (SERS)-Based Sandwich Immunoassays,
Hye-Young Park, Robert J. Lipert, and Marc D. Porter, SPIE Nanosensing:
Materials and Devices 2005, 5593, 464-477.
Low Level Detection of Viral Pathogens by a Surface-Enhanced Raman
Scattering Based Immunoassay, J. D. Driskell, K. M. Kwarta, R. J.
Lipert, M. D. Porter, J. Neill, and J. Ridpath, Anal. Chem. 19 6147-54
(2005).
Ultrasensitive Immunoassays Based on Surface-Enhanced
Raman Scattering by Immunogold Labels, Park, HY; Driskell, JD; Kwarta,
KM; Lipert, RJ; Porter, MD; Schoen, C; Neill, JD; Ridpath, JF, Topics in
Applied Physics, 2006, vol. 103, pp. 427-446.
Detection of Viruses: Atomic Force Microscopy and Surface
Enhanced Raman Spectroscopy, Porter, MD; Driskell, JD; Kwarta, KM;
Lipert, RJ; Neill, JD; Ridpath, JF, Developments in Biologicals, 2006,
vol. 126, pp. 31-40.
Labeled Gold Nanoparticles Immobilized at Smooth Metallic Substrates:
Systematic Investigation of Surface Plasmon Resonance and
Surface-Enhanced Raman Scattering, Driskell, JD; Lipert, RJ; Porter, MD,
Journal of Physical Chemistry B, 2006, vol. 110, no. 35, pp. 17444-17451.
|
| Concurrent Analytical's patent portfolio is comprised of eleven
patents, patent pendings, or provisional patents. These patents
are based on:
1. Raman
active reagents utilizing Extrinsic Raman Label design (SERS)
2.
Monodisperse gold nanoparticle manufacturing
3. Gold
nanorod manufacturing
4.
Multiple patents on reducing incubation times in heterogeneous assays

Many of these technologies are sold as products commercially through
its divisions Nanopartz and Directed Bioflux
|
|